Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of S-1 Plus Oxaliplatin in First-line Treatment of Ederly Patients With Advanced or Recurrent Gastric Cancer

NCT04694404 is registered in ClinicalTrials.gov with Aiping Zhou as lead sponsor.

NCT NCT04694404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04694404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of S-1 Plus Oxaliplatin in First-line Treatment of Ederly Patients With Advanced or Recurrent Gastric Cancer
Lead sponsor
Aiping Zhou
Phase
Phase 2
Overall status
Unknown status
Start date
May 11, 2016
Completion date
December 1, 2022
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

s-1 plus oxaliplatin